Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Successful Treatment of CD19+ Mixed-Phenotype Acute Leukemia With Brexucabtagene Autoleucel Plus Tyrosine Kinase Inhibitor

CT - 976

Successful Treatment of CD19+ Mixed-Phenotype Acute Leukemia With Brexucabtagene Autoleucel Plus Tyrosine Kinase Inhibitor

Molly Gallogly

Poster Presenter: Molly Gallogly

Thumbnail for Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

AML - 350

Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

Vidushi Reddy Gillela

Poster Presenter: Vidushi Reddy Gillela

Thumbnail for Superior 96-weeks MMR rates and safety with generic Dasatinib-50mg in newly diagnosed CML : Large Real-world multicentre study from India

Previous 1...116 117 118 119 120 121 122...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

CML - 1655

Superior 96-weeks MMR rates and safety with generic Dasatinib-50mg in newly diagnosed CML : Large Real-world multicentre study from India

Sujay Rainchwar

Poster Presenter: Sujay Rainchwar

Thumbnail for Survival and Cardiovascular Outcomes Associated With GLP-1 Receptor Agonist Exposure in Patients With Multiple Myeloma and Metabolic Comorbidities: A Propensity-Matched TriNetX Analysis

MM - 857

Survival and Cardiovascular Outcomes Associated With GLP-1 Receptor Agonist Exposure in Patients With Multiple Myeloma and Metabolic Comorbidities: A Propensity-Matched TriNetX Analysis

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko

Thumbnail for Survival and Early Mortality Disparities in Classical Hodgkin Lymphoma Across the Immunotherapy Era: A SEER Analysis (2010-2022)

HL - 092

Survival and Early Mortality Disparities in Classical Hodgkin Lymphoma Across the Immunotherapy Era: A SEER Analysis (2010-2022)

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Survival and Organ Outcomes in AL Amyloidosis in the Daratumumab Era: A Propensity Score-Matched Real-World Analysis

MM - 894

Survival and Organ Outcomes in AL Amyloidosis in the Daratumumab Era: A Propensity Score-Matched Real-World Analysis

Dhriti Sood

Poster Presenter: Dhriti Sood

Thumbnail for Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

MDS - 1311

Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

Kumar Anmol

Poster Presenter: Kumar Anmol

Thumbnail for Survival Benefit of FLT3 Inhibitor Maintenance After Allo-HSCT in FLT3-ITD AML: A Systematic Review and Reconstructed IPD Meta-Analysis of Randomized Controlled Trials

AML - 1587

Survival Benefit of FLT3 Inhibitor Maintenance After Allo-HSCT in FLT3-ITD AML: A Systematic Review and Reconstructed IPD Meta-Analysis of Randomized Controlled Trials

Sushmitha Venkata Annadatha

Poster Presenter: Sushmitha Venkata Annadatha

Thumbnail for Survival Disparities in Plasmablastic Lymphoma: Independent Association of Hispanic Ethnicity With Inferior Outcomes

ABCL - 171

Survival Disparities in Plasmablastic Lymphoma: Independent Association of Hispanic Ethnicity With Inferior Outcomes

Hien Lau

Poster Presenter: Hien Lau

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors